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Abstract
Objectives—This study investigates the effects of surfactants and drug loading on the drug
release rate from ethylene vinyl acetate (EVA) copolymer. The release rate of nystatin from EVA
was studied with addition of non-ionic surfactants Tween 60 and Cremophor RH 40. In addition,
the effect of increasing drug load on the release rates of nystatin, chlorhexidine diacetate and
acyclovir is also presented.
Method—Polymer casting solutions were prepared by stirring EVA copolymer and nystatin (2.5
wt %) in dichloromethane. Nystatin and surfactants were added in ratios of (1:1), (1:2) and (1:3).
Drug loading was studied with 2.5, 5.0, 7.5, and 10.0% wt. proportions of nystatin, chlorhexidine
diacetate and acyclovir incorporated into a separate polymer. Three drug loaded polymer square
films (3cm × 3cm × 0.08 cm) were cut from dry films to follow the kinetics of drug release at
37°C. 10 ml of either distilled water or PBS was used as the extracting medium that was replaced
daily. PBS was used for nystatin release with addition of surfactants and water was used for the
study on drug loading and surfactant release. The rate of drug release was measured by UV-
spectrophotometer. The amount of surfactant released was determined by HPLC.
Results—The release of nystatin was low in PBS and its release rate increased with the addition
of surfactants. Also, increasing surfactant concentrations resulted in increased drug release rates.
The release rates of chlorhexidine diacetate (p<0.0001), acyclovir (p<0.0003) and nystatin
(p<0.0017) linearly increased with increasing drug loads. The amount of surfactants released was
above the CMC.
Significance—This study demonstrates that the three therapeutic agents show a sustained rate of
drug release from EVA copolymer over extended periods of time. Nystatin release in PBS is low
owing to its poor solubility. Its release rate is enhanced by addition of surfactants and increasing
the drug load as well.
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Introduction
Nystatin is an antifungal drug that is widely used for treating oral infections. It has low
solubility in water and saliva [1]. It is known that the solubility of sparingly water soluble
drugs can be increased through the addition of surfactants [2]. Solubilization of water
insoluble drugs by micelles has long been investigated as a means of improving solubility
for drug delivery [3] and the incorporation of a wide variety of drugs into micelles formed
from a large variety of surfactants in particular non-ionic surfactants have been studied [4,5].
Nystatin release from a chewing gum formulation as drug delivery device with addition of
non-ionic surfactants Tween 60 (polyoxyethylene sorbitan mono stearate), Cremophor RH
40 (polyoxyl 40 hydrogenated castor oil) and Panodan AB 90 (diacetyl tartaric acid esters of
mono and diglycerides of vegetable fats) was studied by Andersen et al [6]. The addition of
surfactants promoted a far higher release of nystatin. There are other reports that have
demonstrated an increase in drug release due to the addition of surfactants [7-10].
The main objective of this study is to investigate the effect of surfactants Tween 60 (Tween)
and Cremophor RH 40 (Cremophor) on the release rate of nystatin from ethylene vinyl
acetate (EVA) copolymer. Our second objective is to study the influence of drug loading on
the rate of release of nystatin, chlorhexidine diacetate and acyclovir from EVA. Our
previous studies have shown the ability of EVA, a biocompatible copolymer to deliver drugs
at constant concentrations for an extended period of time [11-15]. This copolymer system is
able to release the drug over several weeks and therefore may be useful as a drug carrier in
the treatment of oral infections.
Materials and Methods
The materials used in this study are detailed in Table 1.
Preparation of thin polymer films
Drug loaded EVA polymer films were prepared by solvent evaporation technique according
to our earlier studies [11-15]. Nystatin loaded samples with surfactants Tween and
Cremophor were prepared similarly in drug to surfactant ratios of (1:1), (1:2) and (1:3). For
the experiment on the effect of surfactants on nystatin release, nystatin incorporated was 2.5
wt % of EVA. The release rates from these samples were compared to those of nystatin
alone in order to study the effect of surfactants. In addition, drug loading was studied with
2.5, 5.0, 7.5, and 10.0% wt. proportions of nystatin, chlorhexidine diacetate, and acyclovir
incorporated into a separate polymer.
Determination of release rate
Three drug loaded polymer square films (3cm × 3cm × 0.08 cm) were cut from dry films to
follow the kinetics of drug release at 37°C. 10 ml of either distilled water or PBS was used
as the extracting medium. The release of nystatin with surfactants was studied in PBS while
water was used for the release study of increasing loads of chlorhexidine diacetate, acyclovir
and nystatin. Fresh 10 ml samples of the media were used daily for 12-14 days and the
extracts were analyzed for a decrease in concentration by measuring the optical density
(OD) spectrophotometrically (Hitachi U-2810 Spectrophotometer) at wavelengths (λmax)
where the maximum absorption occurred. The λmax values were 306, 257.5 and 253 nm for
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nystatin, chlorhexidine diacetate and acyclovir respectively. Using standard plots of OD vs.
concentration, the drug concentration was determined each day.
UV spectral measurements were also made for the two surfactants Tween and Cremophor.
The surfactants did not exhibit any absorbance in the region 200-400 nm and did not
interfere with the determination of absorbance values for nystatin. Also, the standard plots of
nystatin were similar with and without the addition of surfactants.
The amount of Tween and Cremophor released from the nystatin loaded EVA films in water
at 37°C was determined by High Performance Liquid Chromatography (HPLC). The used
HPLC set up was equipped with a Waters Atlantis dC18 3.9 × 150 mm, a Waters 2695
separation module, a Waters 2420 evaporative light scattering detector with settings 75%
nebulizer heater level; 80 °C drift tube temperature; 20 gain; 30 psi nitrogen gas. The mobile
phase was a mixture of A (85 % Fisher HPLC Grade Water) and B (15 % Fisher HPLC
Grade acetonitrile) with a gradient elution of 70% A and 30 %B for the first 5 minutes and
85 % A and 15 % B for the next 11 minutes. The flow rate was 1.00 ml/min and sample
injection was 20 μL. Using standard surfactant plots, the concentration of the surfactant
released from the EVA films was measured.
Determination of solubility of drugs
Solubility of the three drugs chlorhexidine diacetate, acyclovir and nystatin was determined
individually in 5 ml of water by stirring a saturated solution of the drug at 37 °C for 24
hours. The excess drug was filtered and the solution was analysed by UV spectrophotomer.
Statistical Analysis
For each study, one-way analysis of variance was applied to the drug release rates
transformed to the log scale to achieve approximate normality and variance homogeneity. If
the overall F-test for drug with/without surfactant was statistically significant at the .05
level, nine post-hoc contrasts were tested. Six of these comparisons involved the assessment
of the impact of adding surfactant in various ratios: nystatin alone vs. nystatin + cremophor
(1:1), nystatin alone vs. nystatin + Tween (1:1), mixtures of 1:1 ratio vs. those of 1:2 ratio,
and of 1:2 ratio vs. those of 1:3 ratio for Cremophor vs. Tween, respectively. The final three
contrasts pertained to comparing Cremophor vs. Tween with the drug to surfactant ratio
fixed at one of the three levels. Bonferroni adjustments were made for multiple testing
within these two sets of pairwise comparisons for ratios. For the assessment of ratios we
defined p-value < .05/6 = 0.008 as statistically significant. For the comparison of surfactants
we defined p-value < .05/3 = 0.017 as statistically significant. Finally, one-way ANOVAs
were performed to assess the effect of loading of chlorhexidine diacetate, acyclovir and
nystatin ranging from 2.5 % to 10.0 % wt. in EVA. When the percent weight was
statistically significant (i.e. p < .05), pairwise comparisons of 2.5% vs. 5.0%, 5.0% vs. 7.5%,
and 7.5% vs. 10.0 were conducted with Bonferroni adjusted p-value criterion < .05/3 = .017.
Results
Table 2 shows the release rates of nystatin and nystatin with surfactants in PBS at 37°C
respectively. Eighteen of 21 linear regression fits to the cumulative release data that had R2
> .95 (with the lowest R2 = 0.89) supporting use of linear regression to estimate rates for the
range of time in days examined. The effect of surfactant content on nystatin release was
studied in PBS medium (Figures 1 and 2). Analysis of the data shows that the cumulative
release of nystatin is 0.87 μg/cm2.day. Generally, addition of surfactants resulted in an
increase in the release rate of nystatin (Overall F-test p-value <.001). The increase in
surfactant content resulted in a 1.1 to 4.3 times higher nystatin release rate with the addition
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of Tween and a 1.1 to 2.3 times higher release rate with the addition of Cremophor. A
comparison of ratios resulted in no statistically significant differences between nystation
alone versus either Tween added (p = .132) or Cemophor added (p = .031) in a 1:1 ratio.
However, in all four comparisons of 1:1 vs. 1:2 or 1:2 vs. 1:3 (for each surfactant) the higher
ratio resulted in significantly higher release rate (all p < .008). At fixed ratio, addition of
Tween did not result in a significantly different release rate than addition of Cremophor for
1:1 ratio, but Tween did result in a higher rate for ratios of 1:2 and 1:3 (both p < .001).
Table 3 shows the amount of Tween and Cremophor released from nystatin loaded EVA
films in water at 37 °C. The surfactant released was between 1.2-2.6 mg/ml on day 1 and
decreased by about 30-50 % by day 3.
Figure 3 shows the chlorhexidine diacetate release rate with increasing drug loads in water
at 37°C. All linear regression fits to cumulative release data gave R2 >.95. This graph is
representative of the other drugs included in the study.
Table 4 summarizes the data on the effect of loading of chlorhexidine diacetate, acyclovir
and nystatin ranging from 2.5 % to 10.0 % wt. in EVA on the release rate of the drugs. The
release rate increased as the drug load increased for chlorhexidine diacetate, acyclovir and
nystatin, (all p-values < 0.001). Regarding post-hoc comparisons, for Acyclovir, 2.5% was
statistically different than 5.0 % (p=.002), but 5.0% was not significantly different from
7.5% (p=.032) nor was 7.5% statistically different from 10.0% (p=.082). For chlorhexidine
diacetate, all drug loading pairs were statistically different (all p < .002). Finally, for
Nystatin, 2.5% was statistically different than 5.0% (p<.001), 7.5% was statistically different
from 10.0% (p=.001), but 5.0% was not significantly different from 7.5% (p=.36).
The solubility of chlorhexidine diacetate, acyclovir and nystatin in water at 37 °C were
found to be 20, 2.67 and 0.715 mg/ml respectively.
Discussion
This study demonstrated that the three therapeutic agents show a sustained rate of drug
release from EVA copolymer over extended periods of time. This study also showed that the
rate of drug release increased with increasing addition of surfactant in the case of nystatin
and with increasing drug loading in EVA up to 10.0 wt. %.
Effect of solubilizing agents on the rate of nystatin release
When surfactant molecules are dissolved in water at concentrations above the critical
micelle concentrations (cmc), they form aggregates known as micelles. An important
property of the micelles that has particular significance in pharmacy is their ability to
increase the solubility of sparingly soluble substances in water. Release rate of nystatin
increased with addition of surfactants owing to the micellar formation by surfactants that
solubilizes the poorly soluble nystain in aqueous environments. Also, it is possible that the
surfactant lowers the interfacial tension between the polymer matrix and the dissolution
medium; hence it will increase the dispersability of the polymer matrix containing the drug
and will also increase the release rate. Perhaps the surfactant acts as a wicking agent,
causing the fluid to enter the matrix, the surfactant may then dissolve and form channels
from which the drug release may be affected [9].
At surfactant concentration above the cmc, the solubility increases linearly with the
concentration of surfactant indicating that solubilization is related to micellization [2]. As
the proportion of surfactant with respect to nystatin concentration is increased, the release
rate of nystatin increased. This may be explained due to the increase of micelles, as a result
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of the increased surfactant proportion. The increase in micelles enhances the solubilization
of the drug. It was also speculated that increasing amounts of surfactants in the copolymer
system together with the drug, increases the porosity facilitating the enhanced diffusion of
drug molecules through the channels present in the matrix (EVA matrix), leading to an
increase in the rate of drug release [9].
Analysis of the data in Table 3 revealed that the amount of Tween and Cremophor released
from the nystatin loaded EVA films with respect to all nystatin to surfactant compositions
[(1:1), (1:2) and (1:3)] was well above the cmc. The cmc for Tween 60 is 0.023 mM (30μg/
ml) [16] and that for Cremophor RH 40 is ~0.039 % [17].
Addition of surfactants to nystatin in the EVA films has resulted in promoting release of
nystatin that was not as high as reported in earlier studies of nystatin release from chewing
gum formulation as drug delivery device [6]. This is perhaps due to the difference in the
drug delivery device. The EVA material is a hydrophobic copolymer while the chewing gum
formulation constitutes about 50-60% gum base and the rest are sweetening agents,
flavoring agents etc that are hydrophilic [18] thereby rendering the chewing gum more
hydrophilic than EVA. The extent to which solubilization of poorly soluble drug in aqueous
medium depends on the formation of micelles which is facilitated in the drug carrier. It may
be explained that the micelle formation is occurring more in the chewing gum than EVA and
thereby the nystatin release was far higher in case of chewing gum than EVA. Additionally,
chewing gum during service performance constantly undergoes conformational changes
with an actively renewed surface over which mechanical forces are imposed. Therefore
among several factors, perhaps the above two are responsible for the observed enhanced
nystatin release from chewing gum.
Effect of drug loading
The release rate of the three drugs, nystatin, chlorhexidine diacetate and acyclovir, increased
with increasing drug proportions in the polymer matrix as shown in Table 4 which shows a
relationship between drug loading in the 2.5 to 10.0 wt % in EVA and the release rate of the
drug. Increase in loading of the drug affecting the release kinetics has been reported earlier
[19]. Water diffuses into the matrix through the dispersed phase to dissolve the drug upon
contact. The drug particles, once dissolved, leave behind pores in the polymer matrix. The
drug molecules can then diffuse out through the interconnecting pores.
Analysis of Table 4 shows that the release rate of acyclovir is more than chlorhexidine
followed by nystatin. The release rate of nystatin is less owing to its low solubility in water.
The solubility of chlorhexidine in water is more than acyclovir and based on the solubility of
the drugs in water one would expect the release rate of chlorhexidine to be more than that of
acyclovir and the observed results may be explained due to other factors that influence the
release of a drug from a polymer matrix such as their relative solubility in the polymer
matrix, drug-polymer interactions and their relative diffusion through the channels in the
polymer matrix [8].
Increase in nystatin loading from 2.5 to 10 wt % resulted in rates that were 1.2-1.5 times
higher than addition of surfactants except with nystatin and Tween (1:3) ratio.
Conclusions
1. The release rate of nystatin in PBS increased with the addition of surfactants.
Furthermore, increasing surfactant concentrations resulted in increased drug release
rates.
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2. Increased loading of nystatin, chlorhexidine diacetate and acyclovir in the polymer
matrix resulted in an increase in the release rate of the drug.
3. All three drugs exhibited a linear relationship between loading and release rate.
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Effect of increase in concentration of Tween on the release of nystatin in PBS
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Effect of increase in concentration of Cremophor on the release of nystatin in PBS
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Effect of drug load on the release of chlorhexidine diacetate
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Ethylene vinyl acetate (Elvax 40Wg) (EVA) DuPont
Dichoromethane Mallinckrodt Baker Inc.
Phosphate Buffer Saline (PBS) Sigma-Aldrich
Tween 60 (Tween) Sigma-Aldrich
Cremophor RH 40 (Cremophor) Bayer
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Table 2
Release rate of nystatin and nystatin with addition of surfactants in PBS
Drug with /without surfactant Release Rate in PBS (μg/cm2.day)
*
Nystatin alone 0.87(0.04)
Nystatin + Tween (1:1) 1.02(0.04)
Nystatin + Tween (1:2) 2.88(0.28)
Nystatin + Tween (1:3) 3.77(0.55)
Nystatin + Cremophor (1:1) 0.97(0.02)
Nystatin + Cremophor(1:2) 1.55(0.10)
Nystatin + Cremophor (1:3) 2.00 (0.10)
*
Rate expressed in terms of mean (SD)
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Table 3
Concentration of Tween and Cremophor released in water at 37 °C
Composition of nystatin and surfactant Duration of release 
*
 (Days) Amount of surfactant released (mg/ml)
Nystatin + Tween (1:2) 1 1.121
Nystatin + Tween (1:2) 3 0.542
Nystatin + Tween (1:3) 1 1.933
Nystatin + Tween (1:3) 3 0.615
Nystatin + Tween (1:1) 6 0.320
Nystatin + Cremophor (1:2) 1 1.926
Nystatin + Cremophor (1:2) 3 0.678
Nystatin + Cremophor (1:3) 1 2.56
Nystatin + Cremophor (1:3) 3 1.30
*
Surfactant release shown is measured for one day (24 hours) and the number denotes the particular day of release













Tallury et al. Page 14
Table 4
Release rate with increase in drug load in water
Drug loading in EVA (wt%)
Rate of drug release in water (μg/cm2.day)
*
Acyclovir Chlorhexidine diacetate Nystatin
2.5 2.87(0.97) 2.58 (0.02) 0.97 (0.05)
5.0 6.2(0.24) 4.55 (0.50) 1.74(0.16)
7.5 9.2(0.80) 7.32 (0.53) 1.93(0.17)
10.0 12.0(0.90) 9.52 (0.17) 2.91(0.02)
*
Rate expressed in terms of mean (SD)
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